PMID- 32738431 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20220531 IS - 1873-7544 (Electronic) IS - 0306-4522 (Linking) VI - 443 DP - 2020 Sep 1 TI - The Mitochondria-targeted Peptide, Bendavia, Attenuated Ischemia/Reperfusion-induced Stroke Damage. PG - 110-119 LID - S0306-4522(20)30485-1 [pii] LID - 10.1016/j.neuroscience.2020.07.044 [doi] AB - After ischemic stroke, oxygen and nutrition depletion induce mitochondrial dysfunction, which aggravates brain injury. Bendavia, a mitochondria-targeted tetra-peptide, has anti-oxidative and anti-inflammatory activities. We previously reported that bendavia protected human brain microvascular endothelial cells against oxygen/glucose deprivation (OGD)-induced damage via preserving mitochondrial function. The effects of bendavia on mitochondrial function include the inhibition of reactive oxygen species (ROS) production, inhibition of apoptosis, and restoration of adenosine tri-phosphate synthesis. However, the influence of bendavia on the blood-brain barrier (BBB) and neurons after brain ischemia/reperfusion damage is unclear. The aim of this study was to investigate whether bendavia has protective effects against ischemia/reperfusion damage using both in vivo and in vitro models. The in vivo experiments were conducted in mice, which were subjected to transient middle cerebral occlusion (t-MCAO) to induce brain ischemia/reperfusion damage. After t-MCAO, the cerebral blood flow (CBF), neurological deficits, infarct volume, BBB permeability, and microglia/macrophage activation were assessed. Compared to the vehicle group, bendavia administration (administered twice; immediately after reperfusion and 4 h later) attenuated the sensori-motor dysfunction and infarct formation independent of CBF variation. In addition, bendavia decreased BBB hyper-permeability and microglia/macrophage activation. The in vitro experiments were conducted utilizing two models: (1) OGD/re-oxygenation (OGD/R) or (2) hydrogen peroxide (H(2)O(2))-induced neuron damage. In both models, bendavia inhibited neuronal cell death induced by OGD/R or H(2)O(2). These findings indicated that bendavia attenuated brain ischemia/reperfusion damage and has direct neuroprotective effects against cell injury. Therefore, bendavia may be a novel therapeutic agent to improve ischemic stroke patient outcome. CI - Copyright (c) 2020 IBRO. Published by Elsevier Ltd. All rights reserved. FAU - Imai, Takahiko AU - Imai T AD - Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu 501-1196, Japan. FAU - Matsubara, Hirofumi AU - Matsubara H AD - Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu 501-1196, Japan; Department of Neurosurgery, School of Medicine, Gifu University, Gifu 501-1194, Japan. FAU - Nakamura, Shinsuke AU - Nakamura S AD - Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu 501-1196, Japan. FAU - Hara, Hideaki AU - Hara H AD - Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu 501-1196, Japan. FAU - Shimazawa, Masamitsu AU - Shimazawa M AD - Molecular Pharmacology, Department of Biofunctional Evaluation, Gifu Pharmaceutical University, Gifu 501-1196, Japan. Electronic address: shimazawa@gifu-pu.ac.jp. LA - eng PT - Journal Article DEP - 20200730 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Neuroprotective Agents) RN - 0 (Oligopeptides) RN - 0 (arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide) RN - BBX060AN9V (Hydrogen Peroxide) SB - IM MH - Animals MH - *Brain Ischemia/drug therapy MH - Endothelial Cells MH - Hydrogen Peroxide MH - Ischemia MH - Mice MH - Mitochondria MH - *Neuroprotective Agents/pharmacology MH - Oligopeptides MH - Reperfusion MH - *Reperfusion Injury/drug therapy MH - *Stroke OTO - NOTNLM OT - bendavia OT - blood-brain barrier OT - brain ischemia OT - microglia/macrophage OT - neuron OT - oxygen-glucose deprivation/re-oxygenation (OGD/R) EDAT- 2020/08/02 06:00 MHDA- 2021/05/15 06:00 CRDT- 2020/08/02 06:00 PHST- 2020/05/21 00:00 [received] PHST- 2020/07/21 00:00 [revised] PHST- 2020/07/22 00:00 [accepted] PHST- 2020/08/02 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2020/08/02 06:00 [entrez] AID - S0306-4522(20)30485-1 [pii] AID - 10.1016/j.neuroscience.2020.07.044 [doi] PST - ppublish SO - Neuroscience. 2020 Sep 1;443:110-119. doi: 10.1016/j.neuroscience.2020.07.044. Epub 2020 Jul 30.